» Articles » PMID: 35933388

Neuropathology in Chronic Traumatic Encephalopathy: a Systematic Review of Comparative Post-mortem Histology Literature

Overview
Publisher Biomed Central
Specialty Neurology
Date 2022 Aug 6
PMID 35933388
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with repetitive head trauma and is characterised by the perivascular accumulation of hyperphosphorylated tau (p-tau) in the depths of cortical sulci. CTE can only be diagnosed postmortem and the cellular mechanisms of disease causation remain to be elucidated. Understanding the full scope of the pathological changes currently identified in CTE is necessary to identify areas requiring further research. This systematic review summarises the current literature on CTE pathology from postmortem human tissue histology studies published until 31 December 2021. Publications were included if they quantitively or qualitatively compared postmortem human tissue pathology in CTE to neuropathologically normal cases or other neurodegenerative diseases such as Alzheimer's disease (AD). Pathological entities investigated included p-tau, beta-amyloid, TDP-43, Lewy bodies, astrogliosis, microgliosis, axonopathy, vascular dysfunction, and cell stress. Of these pathologies, p-tau was the most frequently investigated, with limited reports on other pathological features such as vascular dysfunction, astrogliosis, and microgliosis. Consistent increases in p-tau, TDP-43, microgliosis, axonopathy, and cell stress were reported in CTE cases compared to neuropathologically normal cases. However, there was no clear consensus on how these pathologies compared to AD. The CTE cases used for these studies were predominantly from the VA-BU-CLF brain bank, with American football and boxing as the most frequent sources of repetitive head injury exposure. Overall, this systematic review highlights gaps in the literature and proposes three priorities for future research including: 1. The need for studies of CTE cases with more diverse head injury exposure profiles to understand the consistency of pathology changes between different populations. 2. The need for more studies that compare CTE with normal ageing and AD to further clarify the pathological signature of CTE for diagnostic purposes and to understand the disease process. 3. Further research on non-aggregate pathologies in CTE, such as vascular dysfunction and neuroinflammation. These are some of the least investigated features of CTE pathology despite being implicated in the acute phase response following traumatic head injury.

Citing Articles

Perivascular glial reactivity is a feature of phosphorylated tau lesions in chronic traumatic encephalopathy.

Osterman C, Hamlin D, Suter C, Affleck A, Gloss B, Turner C Acta Neuropathol. 2025; 149(1):16.

PMID: 39921702 PMC: 11807024. DOI: 10.1007/s00401-025-02854-x.


Repetitive Mild Closed-Head Injury Induced Synapse Loss and Increased Local BOLD-fMRI Signal Homogeneity.

Markicevic M, Mandino F, Toyonaga T, Cai Z, Fesharaki-Zadeh A, Shen X J Neurotrauma. 2024; 41(23-24):2528-2544.

PMID: 39096127 PMC: 11698675. DOI: 10.1089/neu.2024.0095.


Reactive gliosis in traumatic brain injury: a comprehensive review.

Amlerova Z, Chmelova M, Anderova M, Vargova L Front Cell Neurosci. 2024; 18:1335849.

PMID: 38481632 PMC: 10933082. DOI: 10.3389/fncel.2024.1335849.


Intimate Partner Violence-Related Brain Injury: Unmasking and Addressing the Gaps.

Esopenko C, Jain D, Adhikari S, Dams-OConnor K, Ellis M, Haag H J Neurotrauma. 2024; 41(19-20):2219-2237.

PMID: 38323539 PMC: 11564844. DOI: 10.1089/neu.2023.0543.


Genetic ablation of Sarm1 attenuates expression and mislocalization of phosphorylated TDP-43 after mouse repetitive traumatic brain injury.

Dogan E, Bouley J, Zhong J, Harkins A, Keeler A, Bosco D Acta Neuropathol Commun. 2023; 11(1):206.

PMID: 38124145 PMC: 10731794. DOI: 10.1186/s40478-023-01709-4.


References
1.
Zhang L, Yang W, Li X, Dove A, Qi X, Pan K . Association of life-course traumatic brain injury with dementia risk: A nationwide twin study. Alzheimers Dement. 2022; 19(1):217-225. PMC: 10078668. DOI: 10.1002/alz.12671. View

2.
McKee A, Gavett B, Stern R, Nowinski C, Cantu R, Kowall N . TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J Neuropathol Exp Neurol. 2010; 69(9):918-29. PMC: 2951281. DOI: 10.1097/NEN.0b013e3181ee7d85. View

3.
Bieniek K, Cairns N, Crary J, Dickson D, Folkerth R, Keene C . The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy. J Neuropathol Exp Neurol. 2021; 80(3):210-219. PMC: 7899277. DOI: 10.1093/jnen/nlab001. View

4.
Goldstein L, Fisher A, Tagge C, Zhang X, Velisek L, Sullivan J . Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model. Sci Transl Med. 2012; 4(134):134ra60. PMC: 3739428. DOI: 10.1126/scitranslmed.3003716. View

5.
Stein T, Crary J . Chronic Traumatic Encephalopathy and Neuropathological Comorbidities. Semin Neurol. 2020; 40(4):384-393. PMC: 9969350. DOI: 10.1055/s-0040-1713628. View